InsidersTradesSigma
Track the MACROGENICS, INC. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was reported on 13 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Thomas Spitznagel. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
MACROGENICS, INC. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. It is listed on NASDAQ under the ticker MGNX.